87 results
424B4
PRFX
PainReform Ltd
17 Apr 24
Prospectus supplement with pricing info
4:14pm
for that purpose is required, other than in the United States. You are required to inform yourselves about and to observe any restrictions relating … Pharmaceutics International, a U.S.-based contract manufacturing organization for the purpose of manufacturing our clinical trial batches. As such, our
F-1/A
PRFX
PainReform Ltd
15 Apr 24
Registration statement (foreign) (amended)
9:41am
in any jurisdiction where action for that purpose is required, other than in the United States. You are required to inform yourselves about … International, a U.S.-based contract manufacturing organization for the purpose of manufacturing our clinical trial batches. As such, our clinical and business
F-1/A
EX-4.2
PRFX
PainReform Ltd
15 Apr 24
Registration statement (foreign) (amended)
9:41am
, such number of shares of capital stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately … prior to the applicable record or effective date hereinafter specified, a notice stating (x) the date on which a record is to be taken for the purpose
F-1/A
EX-5.2
PRFX
PainReform Ltd
15 Apr 24
Registration statement (foreign) (amended)
9:41am
to you in connection with the Registration Statement. This opinion may not be relied upon for any other purpose, or furnished to, quoted or relied … upon by any other person, firm or corporation for any purpose, without our prior written consent, except that (A) this opinion may be furnished or quoted
F-1/A
EX-4.4
PRFX
PainReform Ltd
15 Apr 24
Registration statement (foreign) (amended)
9:41am
stock and such exercise price being for the purpose of protecting the economic value of this Warrant immediately prior to the consummation … on which a record is to be taken for the purpose of such dividend, distribution, redemption, rights or warrants, or if a record is not to be taken
F-1/A
EX-10.23
1atujwscmq8
15 Apr 24
Registration statement (foreign) (amended)
9:41am
F-1/A
EX-4.3
ott49vd1bqw5lyh5wf
15 Apr 24
Registration statement (foreign) (amended)
9:41am
F-1/A
EX-3.1
wus duhhsu928i1yk1
15 Apr 24
Registration statement (foreign) (amended)
9:41am
POS AM
3vq0tl
13 Mar 24
Prospectus update (post-effective amendment)
8:00am
F-1
EX-107
hnh2brb6
1 Mar 24
Registration statement (foreign)
4:34pm
F-1
rzz33scbci
1 Mar 24
Registration statement (foreign)
4:34pm
424B3
hy4s5nsc
19 Jan 24
Prospectus supplement
4:30pm
F-3
EX-5.1
smj558g z1q
12 Jan 24
Shelf registration (foreign)
4:15pm
F-3
EX-107
fo03cwt02asg7a9y2
12 Jan 24
Shelf registration (foreign)
4:15pm
F-3
es31s
12 Jan 24
Shelf registration (foreign)
4:15pm
6-K
EX-10.1
4jp hfkjm5qonrx
27 Dec 23
Inducement Offer to Exercise Warrants Issued in July 2023
4:01pm
6-K
EX-10.3
wtw188
27 Dec 23
Inducement Offer to Exercise Warrants Issued in July 2023
4:01pm